Completed

PAWSEffects of Acetaminophen on Pain Response Among Overweight or Obese Women Exposed to Weight Stigmatization

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected at a single point in time - Cross-sectional
DNA Samples
Who is being recruted

Weight Prejudice+12

+ Behavior

+ Body Weight

Over 18 Years
See all eligibility criteria
How is the trial designed

Other

Utilizing specific methods not covered by standard models in order to address unique research questions.
Observational
Study Start: November 2019
See protocol details

Summary

Principal SponsorOhio State University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: November 15, 2019

Actual date on which the first participant was enrolled.

The purpose of this study is to evaluate the influence of weight stigma on emotional functioning and biomarkers of inflammation among overweight and obese women; and to determine the degree to which acetaminophen moderates the stigma-related effects. Participants will provide blood spot and saliva samples upon arrival, and then be randomly assigned to consume either 1,000mg of acetaminophen in liquid form, or a placebo solution. Participants then will complete a series of questionnaires assessing a variety of relevant psychological and behavioral constructs. After this participants will be randomly assigned to read one of two shorts stories and answer a series of questions about their reaction to the story. Finally, participants will answer another series of questionnaires and provide a second saliva sample. Participants will first be adult women in the Columbus, Ohio and surrounding areas with body mass indices considered overweight or obese. A smaller cohort of women with normal weight will be recruited at a later time for purposes of comparison.

Official TitleEffects of Acetaminophen on Pain Response Among Overweight or Obese Women Exposed to Weight Stigmatization
NCT04573426
Principal SponsorOhio State University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

200 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Other

Some studies use unique or mixed approaches that don't fit standard categories. These may include innovative observational methods or studies tailored to specific research questions.


Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Female

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Weight PrejudiceBehaviorBody WeightInflammationNutrition DisordersNutritional and Metabolic DiseasesObesityPathologic ProcessesPrejudiceSigns and SymptomsSocial BehaviorPathological Conditions, Signs and SymptomsOvernutritionOverweightSocial Stigma

Criteria

Inclusion Criteria: * At least 18 years old and biologically female Exclusion Criteria: * Due to the use of acetaminophen in this study, women who report current pregnancy will be excluded from the study due to potential negative effects on pregnancy. The following are additional exclusion criteria: 1. Visual impairment that would impair one's ability to read to the extent that they could not read items on paper or a computer screen. 2. Stopping schooling prior to completing ninth grade. 3. A history of liver disorder and/or alcohol abuse. 4. A current prescription of a drug that contains acetaminophen. 5. Allergy to acetaminophen 6. A score on the Patient Health Questionnaire - 9 depressive symptom scale of 15 or greater. 7. For normal weight participants, a history of overweight or obesity.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

The Ohio State University

Columbus, United StatesOpen The Ohio State University in Google Maps
CompletedOne Study Center